Want to see HK:2633 full AI Analyst Report?

Jacobson Pharma Corporation Limited (2633) Financial Statements

7 Followers

Jacobson Pharma Corporation Limited Financial Overview

Jacobson Pharma Corporation Limited's market cap is currently HK$1.85B. The company's EPS TTM is HK$0.151; its P/E ratio is 6.29; and it has a dividend yield of 9.52%. Jacobson Pharma Corporation Limited is scheduled to report earnings on June 23, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Income Statement
Total Revenue	HK$ 1.57B	HK$ 1.58B	HK$ 1.47B	HK$ 1.79B	HK$ 1.60B
Gross Profit	HK$ 677.90M	HK$ 692.94M	HK$ 620.48M	HK$ 747.17M	HK$ 620.52M
Operating Income	HK$ 353.18M	HK$ 414.60M	HK$ 333.13M	HK$ 319.10M	HK$ 222.89M
EBITDA	HK$ 506.97M	HK$ 558.87M	HK$ 475.11M	HK$ 462.04M	HK$ 415.49M
Net Income	HK$ 301.62M	HK$ 300.83M	HK$ 266.97M	HK$ 251.04M	HK$ 177.67M
Balance Sheet
Cash & Short-Term Investments	HK$ 369.86M	HK$ 509.05M	HK$ 411.94M	HK$ 1.04B	HK$ 478.65M
Total Assets	HK$ 3.56B	HK$ 3.65B	HK$ 3.49B	HK$ 5.38B	HK$ 4.76B
Total Debt	HK$ 910.90M	HK$ 773.21M	HK$ 749.38M	HK$ 1.60B	HK$ 1.41B
Net Debt	HK$ 541.04M	HK$ 264.17M	HK$ 337.44M	HK$ 562.65M	HK$ 931.29M
Total Liabilities	HK$ 1.22B	HK$ 1.17B	HK$ 1.09B	HK$ 2.12B	HK$ 1.80B
Stockholders' Equity	HK$ 2.32B	HK$ 2.45B	HK$ 2.37B	HK$ 2.74B	HK$ 2.49B
Cash Flow
Free Cash Flow	HK$ 200.52M	HK$ 278.39M	HK$ 354.85M	HK$ 585.23M	HK$ 345.89M
Operating Cash Flow	HK$ 336.70M	HK$ 526.78M	HK$ 484.36M	HK$ 648.24M	HK$ 409.76M
Investing Cash Flow	HK$ -232.70M	HK$ -297.76M	HK$ 43.34M	HK$ -44.09M	HK$ -52.75M
Financing Cash Flow	HK$ -242.18M	HK$ -131.30M	HK$ -1.05B	HK$ -45.64M	HK$ -357.89M

Currency in HKD

Jacobson Pharma Corporation Limited Earnings and Revenue History

Income Statement >

Jacobson Pharma Corporation Limited Debt to Assets

Balance Sheet >

Jacobson Pharma Corporation Limited Cash Flow

Cash Flow >

Jacobson Pharma Corporation Limited Forecast EPS vs Actual EPS

Earnings >